We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+10.45%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$3.1B
AUM Growth
+$632M
Cap. Flow
+$447M
Cap. Flow %
14.4%
Top 10 Hldgs %
19.97%
Holding
560
New
236
Increased
69
Reduced
84
Closed
160

Top Buys

Rank Stock Value
1
EBAY icon
eBay
EBAY
+$59.6M
2
SHW icon
Sherwin-Williams
SHW
+$57.5M
3
BBY icon
Best Buy
BBY
+$44.8M
4
SBAC icon
SBA Communications
SBAC
+$43.9M
5
NKE icon
Nike
NKE
+$36.3M

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$67.6M
2
MSFT icon
Microsoft
MSFT
+$45.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$37.1M
4
MDU icon
MDU Resources
MDU
+$36.5M
5
BA icon
Boeing
BA
+$29.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.29%
2 Technology 12.47%
3 Industrials 10.27%
4 Healthcare 7.4%
5 Communication Services 6.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACI icon
401
Albertsons Companies
ACI
$5.86B
– –
-50,000
Closed -$1.15M
AEO icon
402
PUT
American Eagle Outfitters
AEO
$3.03B
– –
-394,200
Closed -$8.34M
AGIO icon
403
CALL
Agios Pharmaceuticals
AGIO
$1.89B
– –
-13,500
Closed -$301K
AMLX icon
404
Amylyx Pharmaceuticals
AMLX
$2.43B
– –
-19,029
Closed -$249K
ANF icon
405
CALL
Abercrombie & Fitch
ANF
$4.9B
– –
-35,000
Closed -$3.09M
ANGO icon
406
AngioDynamics
ANGO
$628M
– –
-304,522
Closed -$2.39M
ANIP icon
407
ANI Pharmaceuticals
ANIP
$1.8B
– –
-51,119
Closed -$2.82M
ARGX icon
408
argenx
ARGX
$52.8B
– –
-5,092
Closed -$1.97M
ARGX icon
409
PUT
argenx
ARGX
$52.8B
– –
-3,500
Closed -$1.33M
ASO icon
410
Academy Sports + Outdoors
ASO
$3.02B
– –
-167,523
Closed -$11.1M
AUPH icon
411
CALL
Aurinia Pharmaceuticals
AUPH
$1.92B
– –
-148,500
Closed -$1.34M
AUPH icon
412
Aurinia Pharmaceuticals
AUPH
$1.92B
– –
-113,550
Closed -$1.02M
AUR icon
413
PUT
Aurora
AUR
$14.2B
– –
-1,170,000
Closed -$5.11M
AVDL
414
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-67,500
Closed -$953K
AVDL
415
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-24,000
Closed -$339K
AVGO icon
416
Broadcom
AVGO
$1.99T
– –
-4,490
Closed -$501K
AXSM icon
417
CALL
Axsome Therapeutics
AXSM
$10.9B
– –
-22,500
Closed -$1.79M
BA icon
418
Boeing
BA
$187B
– –
-114,271
Closed -$29.8M
BIIB icon
419
PUT
Biogen
BIIB
$30.8B
– –
-32,000
Closed -$8.28M
BITO icon
420
ProShares Bitcoin Strategy ETF
BITO
$1.43B
– –
-17,250
Closed -$434K
BLMN icon
421
Bloomin' Brands
BLMN
$764M
– –
-75,064
Closed -$2.11M
BMRN icon
422
CALL
BioMarin Pharmaceuticals
BMRN
$11.7B
– –
-32,500
Closed -$3.13M
BP icon
423
BP
BP
$109B
– –
-22,500
Closed -$797K
BSX icon
424
CALL
Boston Scientific
BSX
$71.1B
– –
-87,500
Closed -$5.06M
CHWY icon
425
Chewy
CHWY
$9.87B
– –
-62,654
Closed -$1.13M
15 16
17
18 19

Similar funds

CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
MSC
MUFG Securities (Canada) New York $3.48B AUM 45.13% 1-Year Est. Return

J. Goldman & Co's Q1 2024 Portfolio in Review

As of Q1 2024, J. Goldman & Co held 560 positions worth $3.1B, up 26% from $2.47B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

J. Goldman & Co deployed $447M of net new capital in Q1 2024, opening 236 new positions and adding to 69 existing holdings. Its largest new stake was Sherwin-Williams: 180,485 shares worth $62.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was PayPal, an estimated $67.6M trimmed.

  • J. Goldman & Co's largest Q1 2024 buy was Sherwin-Williams: 180,485 shares worth $62.7M.
  • J. Goldman & Co added most to eBay in Q1 2024, an estimated $59.6M increase.
  • J. Goldman & Co's biggest Q1 2024 reduction was PayPal, cutting an estimated $67.6M.
  • J. Goldman & Co fully exited MDU Resources in Q1 2024, selling an estimated $36.5M.
  • J. Goldman & Co's ten largest holdings make up 20% of its $3.1B portfolio in Q1 2024.
  • J. Goldman & Co opened 236 new positions and closed 160 in Q1 2024.
  • J. Goldman & Co's portfolio value rose 26% quarter-over-quarter to $3.1B.

Based on J. Goldman & Co's 13F filing for Q1 2024, filed 15 May 2024.